Expression of Monocyte Chemotactic Protein-1 in Human Endometrial Cancer Cells and the Effect of Treatment with Tamoxifen or Buserelin
Authors:
Open Access
- 1 May 2006
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 34 (3) , 284-290
Abstract
Monocyte chemotactic protein-1 (MCP-1) is an important determinant of macrophage infiltration in tumours. This study investigated the effect of tamoxifen and the gonadotrophin-releasing hormone agonist buserelin on MCP-1 in the human endometrial cancer cell line EFE-184. Reverse transcription polymerase chain reaction and Western blot analysis were used to determine MCP-1 mRNA and protein expression, respectively. Immunoreactive MCP-1 in the cell culture media was quantified by enzyme-linked immunosorbent assay. Tamoxifen inhibited MCP-1 mRNA and protein expression in endometrial cancer cells and inhibited MCP-1 secretion in a time- and dose-dependent manner at concentrations of 10−7 to 10−5 M. Buserelin had no significant effect on MCP-1 mRNA and protein expression. These results suggest that tamoxifen directly inhibits the expression of MCP-1 in this cell line by blocking the MCP-1 signalling pathways. These findings may contribute to the understanding of the mechanisms underlying the different effects of tamoxifen and gonadotrophin-releasing hormone agonists in the treatment of endometrial cancer.Keywords
This publication has 12 references indexed in Scilit:
- The gynaecological management of women on tamoxifen: a national questionnaire surveyJournal of Obstetrics and Gynaecology, 2004
- Effects of estradiol and tamoxifen on proliferation of human breast cancer cells and human endometrial cellsCurrent Medical Science, 2003
- Negative regulation of monocyte chemoattractant protein-1 gene expression by a mouse estrogen-enhanced transcriptEuropean Journal of Immunology, 2002
- 17β-estradiol inhibits the adhesion of leukocytes in TNF-α stimulated human endothelial cells by blocking IL-8 and MCP-1 secretion, but not its transcriptionLife Sciences, 2002
- Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinomaCancer, 2001
- Tamoxifen in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2001
- Regulation of endometrial cancer cell growth by luteinizing hormone (LH) and follicle stimulating hormone (FSH)British Journal of Cancer, 2000
- Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progressionBlood, 2000
- Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1International Journal of Cancer, 1999
- Regulation of Monocyte Chemotactic Protein-1 Expression in Human Endometrial Stromal Cells by Estrogen and Progesterone1Biology of Reproduction, 1999